John Stapleton
Nurse Practitioner · Covington, VANPI 1710348354
Payments from drug & device makers
Across 153 payments — averaging $16.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$792
- Otsuka America Pharmaceutical, Inc.$335
- AstraZeneca$291
- Novo Nordisk$271
- Pfizer$231
- Lilly USA, LLC$146
- plus $392 from 10 others
What the payments were for
- Food & beverage$2,458100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 50 | $792 |
| Otsuka America Pharmaceutical, Inc. | 25 | $335 |
| AstraZeneca | 15 | $291 |
| Novo Nordisk | 16 | $271 |
| Pfizer | 14 | $231 |
| Lilly USA, LLC | 9 | $146 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $84 |
| Lundbeck LLC | 5 | $77 |
| Merck | 3 | $53 |
| Amgen | 3 | $51 |
| GSK | 2 | $29 |
| Astellas Pharma US Inc | 2 | $29 |
| Exact Sciences | 1 | $20 |
| Ironshore Pharmaceuticals Inc. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
How this compares
$2,458 in reported general payments places this provider in the 90th percentile of 2,166 nurse practitioner providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OtezlaApremilast | 12 | $60,732 |
| JardianceEmpagliflozin | 34 | $25,154 |
| EliquisApixaban | 35 | $25,069 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 36 | $23,195 |
| FarxigaDapagliflozin Propanediol | 20 | $19,063 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 15 | $9,474 |
| Tresiba Flextouch U-100Insulin Degludec | 19 | $9,303 |
| LinzessLinaclotide | 13 | $8,191 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 119 | $2,845 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 24 | $1,796 |
| Prednisone | 134 | $1,106 |
| Gabapentin | 114 | $1,077 |
| Omeprazole | 73 | $1,005 |
| Levothyroxine Sodium | 107 | $891 |
| Atorvastatin Calcium | 121 | $862 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenOtezla | $51 | $60,73212 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $291 | $28,53835 claims |
| PfizerEliquis | $231 | $25,06935 claims |
| GSKTrelegy Ellipta | $29 | $23,19536 claims |
| AbbVieLinzess | $792 | $8,19113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,166 nurse practitioner providers in Virginia.
Other nurse practitioner in Covington
- Samantha FoxGate City$207K
- Mikel GrayCharlottesville$174K
- Kevin BrigleRichmond$166K
- Denese GomesRichmond$126K
- Ashley CarmenAlexandria$99K
- Rachel AndersonCharlottesville$90K
- Megan FrancisArlington$81K
- Elizabeth WilletteNorfolk$58K
- Lacey LyleSuffolk$50K
- Sasha LeeVirginia Beach$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.